BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND HOXA11, HOX1, 3207, ENSG00000005073, HOX1I, P31270 AND Prognosis
4 results:

  • 1. Expression of the HOXA gene family and its relationship to prognosis and immune infiltrates in cervical cancer.
    Ge F; Tie W; Zhang J; Zhu Y; Fan Y
    J Clin Lab Anal; 2021 Nov; 35(11):e24015. PubMed ID: 34606634
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Deregulation of H19 is associated with cervical carcinoma.
    Roychowdhury A; Samadder S; Das P; Mazumder DI; Chatterjee A; Addya S; Mondal R; Roy A; Roychoudhury S; Panda CK
    Genomics; 2020 Jan; 112(1):961-970. PubMed ID: 31229557
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The long noncoding RNA hoxa11 antisense induces tumor progression and stemness maintenance in cervical cancer.
    Kim HJ; Eoh KJ; Kim LK; Nam EJ; Yoon SO; Kim KH; Lee JK; Kim SW; Kim YT
    Oncotarget; 2016 Dec; 7(50):83001-83016. PubMed ID: 27792998
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. hoxa11 DNA methylation--a novel prognostic biomarker in ovarian cancer.
    Fiegl H; Windbichler G; Mueller-Holzner E; Goebel G; Lechner M; Jacobs IJ; Widschwendter M
    Int J Cancer; 2008 Aug; 123(3):725-9. PubMed ID: 18478570
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.